Sigilon Therapeutics™ is a biotech company based in Cambridge, MA. At Sigilon, our goal is to liberate patients from chronic diseases with our Shielded Living Therapeutics™ platform. Our engineered cell therapies are designed to restore cell function in a person living with a chronic disease or disorder such as rare blood, lysosomal storage or endocrine disorders. We care deeply about patients and caregivers and we are working to create therapies with the potential to deliver functional cures. We envision a future with less fear of “what ifs.” We, together, can deliver on hope.

Click HERE for Sigilon Therapeutics’ QR Code

Sigilon Therapeutics